Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golvatinib with Cisplatin and Capecitabine in Gastric Cancer
NCT01355302Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of Golvatinib in gastric cancer (GC), solid tumor, sponsored by Eisai Co., Ltd.. Started Nov 2011; status: terminated.
02
Drugs
Golvatinib
03
Conditions
gastric cancer (GC)solid tumor
Beyond the preview
Go deeper on NCT01355302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355302.